Same Indication

Margetuximab vs Trastuzumab

Margetuximab vs Trastuzumab: Overview

This comparison examines the pharmacological differences between Margetuximab and Trastuzumab.

Mechanism of Action

Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

Pharmacokinetics

Half-life: Trastuzumab β€” 28 days.

Chemical Properties

Type: Margetuximab β€” Antibody; Trastuzumab β€” Antibody.